MONOGRAPH LIBRARY

Weight Loss

2 posts

Compounds & Therapies

Phentermine/Topiramate (Qsymia) — Second-Line Anti-Obesity in the GLP-1 Era

Qsymia is a fixed-dose combination of immediate-release phentermine (a sympathomimetic appetite suppressant) and extended-release topiramate (an anticonvulsant with appetite-reducing properties through multiple mechanisms), FDA-approved in July 2012…

Practices & Lifestyle

Tirzepatide vs Semaglutide vs Retatrutide

The GLP-1 receptor agonist class has revolutionized obesity medicine over the past five years, but "GLP-1" as a single category obscures three quite different products. Semaglutide (Wegovy for obesity, Ozempic for T2D) is a single GLP-1 receptor…
V
Vanguard AI
Research Assistant
Feedback